KIMBERLY NAGEL: Open Payments
NPI 1003852187 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,578 in 73 payments from 18 companies in 2025. Trend: 2023 $1,513 · 2024 $1,504 · 2025 $1,578
Food & beverage: $1,578
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $328 |
| PFIZER INC. | 15 | $308 |
| Lilly USA, LLC | 10 | $185 |
| Exact Sciences Corporation | 2 | $112 |
| Novartis Pharmaceuticals Corporation | 4 | $82 |
| Currax Pharmaceuticals LLC | 5 | $76 |
| Gilead Sciences, Inc. | 3 | $68 |
| Astellas Pharma US Inc | 3 | $66 |
| ABBVIE INC. | 3 | $65 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $55 |
Products named: NURTEC ODT, AIRSUPRA, MOUNJARO, The Cologuard Plus Collection Kit, LEQVIO, CONTRAVE, Veozah, XIFAXAN.
Industry payments across KS — which companies pay providers there.
